Sectors include semiconductors, frontier tech and electric vehicles
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌
Investments on Propel(x) are high risk, illiquid and bear the risk of partial or complete loss of invested capital. Please review risk factors for investments on Propel(x) here.
This newsletter is for informational purposes only. It is not a solicitation to buy or sell a security.

Were you forwarded this newsletter? Subscribe here
                   1 December 2021                      
Here is what caught our attention over the past few weeks. Watch out for a special article covered at the extreme bottom of this email.
We are reading
Alumni Spotlight - Raydiant Oximetry raised an oversubscribed round of $5 million
Raydiant Oximetry, a clinical-stage medical device company focussed on improving women’s and neonatal health, has raised an oversubscribed round of $5 million Series A2 financing, led by Avestria Ventures and participated by V-Capital, Band of Angels, FemHealth Ventures and a few other VC firms.

Disclosure: Raydiant Oximetry is a Propel(x) alumni company and closed on the platform in April 2018.
Roundtable discussion: Investing in Deep Tech - Getting Ahead of the Curve
Propel(x)'s co-founder and CEO, Swati Chaturvedi was a speaker in a roundtable discussion with other industry experts where they discussed how startups are flipping the script on the lab coat dominated world of deep tech.

Moderated by Eric Cantor from Vincent, speakers included Lacey Johnson from Alumni Ventures and Aaron Burnett from Spaced Ventures. This event has now ended. You can watch a recording by clicking on the re-play button provided below.
MFN - Most Favored Nation clause and how it works when investing
A Most Favored Nation clause, or MFN clause as it is commonly known, protects an investor by giving them the same rights and benefits received by later investors, if those rights and benefits are more favorable than those originally agreed. The primary purpose of an MFN clause in an investment agreement is to give investors comfort that they will not be disadvantaged compared to other investors in subsequent rounds, thus maximizing their potential returns.
Family offices become serious rivals to VC firms for funding start-ups
Sequoia recently announced a fundamental disruption to the traditional venture capital model. As part of this change, they are also becoming a registered investment advisor which expands their flexibility to support their portfolio companies through various financing events such as secondaries and IPOs. The firm is facing intense competition from visionary startup founders whose options for raising capital are no longer restricted to the traditional venture capital route.

"From wealthy individuals and family offices at the seed and early stages, to traditional asset and wealth managers getting in on pre-initial public offering rounds — not to mention hedge funds — investors that may have previously confined themselves to public markets are now clomping all over the VC landscape. Endowments and pension funds, the main providers of cash to VC funds, are also keen to cut out the middleman and invest in start-ups directly."

Source: Financial Times, UK
How would you rate our newsletter?
Top 6 celebrities investing in the technology startup space
Propel(x) is an alternative investment platform facilitating private venture capital for deep technology startups. Our mission is to enable investment in technologies that matter
and thus build the next generation of great companies.

Investors | Founders

Investments on Propel(x) are high risk, illiquid and bear the risk of partial or complete loss of invested capital. Please review risk factors for investments on Propel(x) here.

Email Marketing by ActiveCampaign